Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cocconi

Showing results (121-130 of 151) with videos related to

Pageof 16
Sort By:
Cancer|January 1, 1988
The value of bone marrow biopsy in breast cancer at time of diagnosis. A prospective studyG Ceci, V Franciosi, R Nizzoli, et al.
Cancer|March 1, 1988
The value of bone marrow biopsy in breast cancer at the time of first relapse. A prospective studyG Ceci, V Franciosi, R Passalacqua, et al.
Cancer|April 2, 2005
Lomustine (chloroethylnitrosourea [CCNU]), ifosfamide, bleomycin, vincristine, and cisplatin (CIBO-P) is an effective regimen for patients with poor prognostic refractory or multiple disease recurrent aggressive non-Hodgkin lymphomaAntonino Musolino, Maria Antonietta Perrone, Maria Michiara, et al.
American Journal of Clinical Oncology|December 10, 2003
P-CHOP: cisplatin (P) added to the standard CHOP regimen as first-line treatment for aggressive non-Hodgkin lymphoma: a single-institution phase II studyGiorgio Cocconi, Vittorio Franciosi, Anna Dodero, et al.
Cancer|July 19, 2002
Randomized trial comparing cyclophosphamide, methotrexate, and 5-fluorouracil (CMF) with rotational CMF, epirubicin and vincristine as primary chemotherapy in operable breast carcinomaGiorgio Cocconi, Beatrice Di Blasio, Corrado Boni, et al.
Frontiers in Public Health|October 6, 2023
Health professionals who have worked in COVID-19 immunization centers suffer the effects of violenceLaura Brunelli, Enrico Scarpis, Tancredi Lo Presti, et al.
Melanoma Research|February 6, 2003
Treatment of metastatic malignant melanoma with dacarbazine plus tamoxifen, or vindesine plus tamoxifen: a prospective randomized studyG Cocconi, R Passalacqua, S Foladore, et al.
American Journal of Clinical Oncology|December 22, 1999
Comparison of CMF (cyclophosphamide, methotrexate, and 5-fluorouracil) with a rotational crossing and a sequential intensification regimen in advanced breast cancer: a prospective randomized studyG Cocconi, G Bisagni, M Bella, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1991
Cisplatin and etoposide as first-line chemotherapy for metastatic breast carcinoma: a prospective randomized trial of the Italian Oncology Group for Clinical ResearchG Cocconi, G Bisagni, M Bacchi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 16, 2005
Primary chemotherapy in operable breast carcinoma comparing CMF (cyclophosphamide, methotrexate, 5-fluorouracil) with an anthracycline-containing regimen: short-term responses translated into long-term outcomesG Cocconi, B Di Blasio, C Boni, et al.
Pageof 16

Showing results (121-130 of 151) with videos related to

Sort By:
Pageof 16
Cancer|January 1, 1988
The value of bone marrow biopsy in breast cancer at time of diagnosis. A prospective studyG Ceci, V Franciosi, R Nizzoli, et al.
Cancer|March 1, 1988
The value of bone marrow biopsy in breast cancer at the time of first relapse. A prospective studyG Ceci, V Franciosi, R Passalacqua, et al.
Cancer|April 2, 2005
Lomustine (chloroethylnitrosourea [CCNU]), ifosfamide, bleomycin, vincristine, and cisplatin (CIBO-P) is an effective regimen for patients with poor prognostic refractory or multiple disease recurrent aggressive non-Hodgkin lymphomaAntonino Musolino, Maria Antonietta Perrone, Maria Michiara, et al.
American Journal of Clinical Oncology|December 10, 2003
P-CHOP: cisplatin (P) added to the standard CHOP regimen as first-line treatment for aggressive non-Hodgkin lymphoma: a single-institution phase II studyGiorgio Cocconi, Vittorio Franciosi, Anna Dodero, et al.
Cancer|July 19, 2002
Randomized trial comparing cyclophosphamide, methotrexate, and 5-fluorouracil (CMF) with rotational CMF, epirubicin and vincristine as primary chemotherapy in operable breast carcinomaGiorgio Cocconi, Beatrice Di Blasio, Corrado Boni, et al.
Frontiers in Public Health|October 6, 2023
Health professionals who have worked in COVID-19 immunization centers suffer the effects of violenceLaura Brunelli, Enrico Scarpis, Tancredi Lo Presti, et al.
Melanoma Research|February 6, 2003
Treatment of metastatic malignant melanoma with dacarbazine plus tamoxifen, or vindesine plus tamoxifen: a prospective randomized studyG Cocconi, R Passalacqua, S Foladore, et al.
American Journal of Clinical Oncology|December 22, 1999
Comparison of CMF (cyclophosphamide, methotrexate, and 5-fluorouracil) with a rotational crossing and a sequential intensification regimen in advanced breast cancer: a prospective randomized studyG Cocconi, G Bisagni, M Bella, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1991
Cisplatin and etoposide as first-line chemotherapy for metastatic breast carcinoma: a prospective randomized trial of the Italian Oncology Group for Clinical ResearchG Cocconi, G Bisagni, M Bacchi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 16, 2005
Primary chemotherapy in operable breast carcinoma comparing CMF (cyclophosphamide, methotrexate, 5-fluorouracil) with an anthracycline-containing regimen: short-term responses translated into long-term outcomesG Cocconi, B Di Blasio, C Boni, et al.
Pageof 16